当前位置:首页 - 行情中心 - 祥生医疗(688358) - 财务分析 - 现金流量表

祥生医疗

(688358)

  

流通市值:32.47亿  总市值:32.52亿
流通股本:1.12亿   总股本:1.12亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金214,096,928.9585,825,240.41434,507,555.85323,526,251.41
  收到的税费返还19,865,039.896,085,492.9927,853,696.124,160,075.34
  收到其他与经营活动有关的现金31,924,504.8120,407,033.739,502,054.8226,391,904.08
  经营活动现金流入小计265,886,473.65112,317,767.1501,863,306.77374,078,230.83
  购买商品、接受劳务支付的现金113,916,999.9670,912,394.13205,231,590.34139,883,510.94
  支付给职工以及为职工支付的现金66,590,330.0936,710,268.64126,620,632.694,581,881.5
  支付的各项税费20,776,407.138,380,729.7520,337,022.8420,277,452.02
  支付其他与经营活动有关的现金28,423,649.1813,220,124.5942,505,858.1346,045,103.46
  经营活动现金流出小计229,707,386.36129,223,517.11394,695,103.91300,787,947.92
  经营活动产生的现金流量净额36,179,087.29-16,905,750.01107,168,202.8673,290,282.91
二、投资活动产生的现金流量:
  收回投资收到的现金444,790,800200,590,7001,516,516,282.621,278,486,349.35
  取得投资收益收到的现金366,397.26247,493.153,816,784.123,193,084.12
  处置固定资产、无形资产和其他长期资产收回的现金净额495,920.68-5,570,480.924,270,315.31
  收到的其他与投资活动有关的现金3,236,912.831,230,853.145,686,788.225,014,073.39
  投资活动现金流入小计448,890,030.77202,069,046.291,531,590,335.881,290,963,822.17
  购建固定资产、无形资产和其他长期资产支付的现金12,164,652.064,969,935.4414,407,094.2912,760,925.55
  投资支付的现金490,457,20069,678,0001,459,359,882.621,250,535,421.36
  投资活动现金流出小计502,621,852.0674,647,935.441,473,766,976.911,263,296,346.91
  投资活动产生的现金流量净额-53,731,821.29127,421,110.8557,823,358.9727,667,475.26
三、筹资活动产生的现金流量:
  吸收投资收到的现金--3,735,750-
  筹资活动现金流入平衡项目--0-
  筹资活动现金流入小计--3,735,750-
  分配股利、利润或偿付利息支付的现金33,637,683.933,637,683.9111,874,753111,874,753
  支付其他与筹资活动有关的现金1,165,235.34473,853.794,398,999.674,116,634.67
  筹资活动现金流出小计34,802,919.2434,111,537.69116,273,752.67115,991,387.67
  筹资活动产生的现金流量净额-34,802,919.24-34,111,537.69-112,538,002.67-115,991,387.67
四、汇率变动对现金及现金等价物的影响-22,018,896.19-12,966,786.29-30,544,053.35-4,939,828.76
五、现金及现金等价物净增加额-74,374,549.4363,437,036.8621,909,505.81-19,973,458.26
  加:期初现金及现金等价物余额840,572,827.86840,572,827.86818,663,322.05818,703,836.07
  期末现金及现金等价物余额766,198,278.43904,009,864.72840,572,827.86798,730,377.81
补充资料:
  净利润68,957,612.85-116,499,752.06-
  资产减值准备1,991,278.82-4,314,477.93-
  固定资产和投资性房地产折旧4,248,669.38-9,147,146.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧4,248,669.38-9,147,146.72-
  无形资产摊销423,162.76-1,373,825.57-
  长期待摊费用摊销--893,119.15-
  处置固定资产、无形资产和其他长期资产的损失-421,892.84--4,525,956.56-
  公允价值变动损失-226,776.94---
  财务费用-192,597.67-11,446,093.17-
  投资损失-345,657.79--3,429,755.01-
  递延所得税492,465.4--2,733,516.05-
  其中:递延所得税资产减少492,465.4--2,733,516.05-
  存货的减少-18,659,042.64--7,029,025.22-
  经营性应收项目的减少-20,169,855.62--35,678,578.26-
  经营性应付项目的增加-4,622,439.81-12,051,360.47-
  其他1,054,017.89--56,186.2-
  现金的期末余额766,198,278.43-840,572,827.86-
  减:现金的期初余额840,572,827.86-818,663,322.05-
  现金及现金等价物的净增加额-74,374,549.43-21,909,505.81-
公告日期2026-08-282026-04-282026-04-202025-10-20
审计意见(境内)标准无保留意见
TOP↑